The Claim
In rat models of liver injury induced by CCl4, paracetamol, or diclofenac, administration of BPC 157 is associated with reduced tissue damage and is linked to antioxidant mechanisms that mitigate chemical hepatotoxicity.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rats with chemical-induced liver injury, BPC 157 reduces tissue damage through antioxidant activity.
See the scientific wording
In rat models of liver injury induced by CCl4, paracetamol, or diclofenac, BPC 157 administration was associated with reduced tissue damage, suggesting a protective effect against chemical hepatotoxicity through antioxidant mechanisms.
BPC 157 neutralizes harmful molecules produced by liver toxins, stopping them from breaking down liver cells and causing damage.
What the research says
1 studyStudy: Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
In rats with liver damage from toxic chemicals, BPC 157 helped heal the liver and reduced harm — likely by soaking up harmful molecules that cause damage, like a sponge for toxins.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.